Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacokinetics of High-dose Tigecycline in Critically Ill Patients: an Observational, Prospective Study

NCT03034174 is registered in ClinicalTrials.gov with Medical University of Lublin as lead sponsor.

NCT NCT03034174
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03034174 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacokinetics of High-dose Tigecycline in Critically Ill Patients: an Observational, Prospective Study
Lead sponsor
Medical University of Lublin
Phase
Observational
Overall status
Completed
Start date
January 15, 2017
Completion date
October 10, 2018
Enrollment
37 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

antibiotic resistant infection, critical illness, septic shock